FDA approves new COVID vaccines

The FDA has approved updated COVID-19 vaccines from Moderna, Novavax-Sanofi, and Pfizer-BioNTech targeting the dominant JN.1 lineage XFG subvariant for adults 65+ and younger high-risk individuals. These approvals differ by vaccine brand and coverage age groups, with distribution beginning soon and insurance coverage largely assured through 2027.

This Wire brief sits within Fusion42's coverage of Health, and 4 sources have reported it.